Genetic Testing Gaps
Testing for hereditary mutations is increasingly recommended for people with cancer, but recommendations do not always translate into access to testing and appropriate counseling.
by Kate Yandell
Patient Advocates Tune in for Precision Medicine Primer
Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers.
by Kevin McLaughlin
Liquid Biopsies May Ease Enrollment in Clinical Trials
A study shows that a blood test for gastrointestinal tumor mutations gave results in a third of the time needed for solid tissue testing. Patients who received the blood test were more likely to enroll in clinical trials.
by Emma Yasinski
Taking Drug Dosing Off Autopilot
Patient advocates with metastatic breast cancer argue that dosing of treatments for their disease should be more personalized and take into account quality of life.
by Marcus A. Banks
Targeted Therapy for Early-Stage Lung Cancer?
A trial of the targeted therapy Tagrisso (osimertinib) for early-stage lung cancer finds that patients who take it go longer without having a cancer recurrence. Whether that should change clinical practice is under discussion.
by Ashley P. Taylor
What is a Super Responder?
Researchers are investigating why certain patients have an exceptional response to a particular drug.
by Bradley Jones
Tumor Testing May Help Guide Pancreatic Cancer Treatment
For a small group of pancreatic cancer patients who were able to receive therapies targeting the molecular alterations in their tumors, these matched therapies were associated with longer life.
by Cheryl Platzman Weinstock
Despite Generic Imatinib, Cost of Treating CML Remains High
The arrival of generic versions of the targeted therapy imatinib only modestly reduced the cost of treating chronic myelogenous leukemia patients, a study finds.
by Anna Azvolinsky
New Drugs for an Elusive Cancer Target
Medical oncologist and lung cancer expert Roy S. Herbst discusses early data on drugs that target a mutated form of the KRAS protein.
by Anna Azvolinsky
Clinical Trials: An African American Survivor’s Experience
Melvin Mann benefited from joining a pivotal clinical trial for chronic myelogenous leukemia, but participation came with logistical challenges.
by Melvin Mann
AACR patient advocate forum explores how new clinical trial designs are accelerating drug testing.
by Thomas CelonaFinding Your Niche
Support groups offer community for people with cancer in a world that doesn’t understand their experience.
by Carly FlumerMaking Informed Consent Accessible
Confusing informed consent forms are a common barrier to clinical trial participation. Researchers ask how they can be better designed for patients.
by Sandra GordonKeep That Colonoscopy Appointment
Experts weigh in on a recent study appearing to show that colonoscopy had lower-than-expected efficacy for preventing colorectal cancer.
by Pamela Rafalow Grossman